Global Atherectomy and Thrombectomy Devices Market 2015-2019

Global Atherectomy and Thrombectomy Devices Market 2015-2019

Category : Medical Devices
Published On : August  2015
Pages : 83



TOLL FREE
+1-971-202-1575
------------ Or -------------
help@researchbeam.com
About Atherectomy and Thrombectomy Devices
Atherectomy devices are used to remove atherosclerotic plaques to clear blocked blood vessels. Atherosclerotic plaques are deposits of fats, calcium, or other substances inside the blood vessels. It is an endovascular procedure for the treatment of PAD and CAD. PVD refers to damaged or blocked peripheral blood vessels that supply blood to the arms, legs, and organs other than brain and heart. PAD, which is PVD of the arteries, is known to increase the risk of stroke and heart attack by up to six times. CAD is a condition of narrowing of arteries that supply blood to heart muscles. Stents, balloon catheters, atherectomy devices are used in endovascular procedures to treat PVD. Thrombectomy devices are used to surgically remove thrombi (clot) from the blood vessels during the treatment of DVT. DVT is the blood clot formed in deep veins in the body, mainly in legs. The risk of developing these vascular diseases increases with age. Diabetes, high blood pressure, obesity, and smoking are other risk factors for these diseases.

Technavios analysts forecast the global atherectomy and thrombectomy market to grow at a CAGR of 6.25% over the period 2014-2019.

Covered in this Report
The report includes the present scenario and the growth prospects of the global atherectomy and thrombectomy devices market for the period 2015-2019. The market can be segmented into two divisions: atherectomy devices and thrombectomy devices.

Technavios report, Global Atherectomy and Thrombectomy Devices Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the landscape of the global atherectomy and thrombectomy devices market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key Regions
• Americas
• APAC
• EMEA

Key Vendors
• Boston Scientific Group
• Cardiovascular Systems 
• Medtronic 
• Spectranetics 

Other Prominent Vendors
• Argon Medical Devices
• C.R. Bard
• Cod Man Neuro (DePuy Orthopaedics)
• Cook Medical
• Edwards Lifesciences
• IDEV Technologies (subsidiary of Abbott Vascular)
• Lake Region Medical
• NexGen Medical Systems
• Reverse Medical
• St. Jude Medical
• Teleflex Medical
• Volcano (acquired by Philips)

Key Market Driver
• Growing Prevalence of PAD and DVT
• For a full, detailed list, view our report

Key Market Challenge
• Product Recalls
• For a full, detailed list, view our report

Key Market Trend
• Growing Number of Acquisitions
• For a full, detailed list, view our report

Key Questions Answered in this Report
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

03.1 Market Overview

03.2 Product Offerings

03.2.1 Atherectomy Products

03.2.2 Thrombectomy Products

04. Market Research Methodology

04.1 Market Research Process

04.2 Research Methodology

05. Introduction

06. Global Atherectomy and Thrombectomy Devices Market

06.1 Market Overview

06.1.1 Market Size and Forecast

07. Global Atherectomy and Thrombectomy Market Segmentation by Product Type

07.1 Atherectomy Devices

07.2 Thrombectomy Devices

07.3 Five Forces Analysis

08. Global Atherectomy Devices Market

08.1 Market Overview

08.1.1 Market Size and Forecast

08.2 Market Segmentation by Procedure Type

09. Global Thrombectomy Devices Market

09.1 Market Overview

09.1.1 Market Size and Forecast

09.2 Market Segmentation by Product Type

09.3 Market Segmentation by Procedure Type

10. Reimbursement Scenario of Atherectomy and Thrombectomy Devices

10.1 Reimbursement Scenario in Americas

10.2 Reimbursement Scenario in EMEA

10.3 Reimbursement Scenario in APAC

11. Geographical Segmentation

11.1 Atherectomy and Thrombectomy Devices Market in the Americas

11.1.1 Market Size and Forecast

11.2 Atherectomy and Thrombectomy Devices Market in EMEA

11.2.1 Market Size and Forecast

11.3 Atherectomy and Thrombectomy Devices Market in APAC

11.3.1 Market Size and Forecast

12. Buying Criteria

13. Market Growth Drivers

14. Drivers and their Impact

15. Market Challenges

16. Impact of Drivers and Challenges

17. Market Trends

18. Trends and their Impact

19. Vendor Landscape

19.1 Competitive Scenario

19.1.1 Key News

19.1.2 Mergers and Acquisitions

19.2 Market Share Analysis 2014

19.3 Other Prominent Vendors

20. Key Vendor Analysis

20.1 Boston Scientific

20.1.1 Key Facts

20.1.2 Business Overview

20.1.3 Business Segmentation

20.1.4 Business Strategy

20.1.5 Business Segmentation by Revenue

20.1.6 Business Segmentation by Revenue 2012 and 2013

20.1.7 Geographical Segmentation by Revenue

20.1.8 Key Developments

20.1.9 SWOT Analysis

20.2 Cardiovascular Systems

20.2.1 Key Facts

20.2.2 Business Overview

20.2.3 Product Segmentation Based on Therapy Areas

20.2.4 Business Strategy

20.2.5 Recent Developments

20.2.6 SWOT Analysis

20.3 Medtronic

20.3.1 Key Facts

20.3.2 Business Overview

20.3.3 Business Segmentation

20.3.4 Revenue by Business Segmentation

20.3.5 Revenue Comparison by Business Segmentation 2012 and 2013

20.3.6 Revenue by Geographical Segmentation

20.3.7 Business Strategy

20.3.8 Key Developments

20.3.9 SWOT Analysis

20.4 Spectranetics

20.4.1 Key Facts

20.4.2 Business Overview

20.4.3 Business Segmentation 2014

20.4.4 Business Segmentation by Revenue 2013 and 2014

20.4.5 Geographical Segmentation by Revenue 2014

20.4.6 Business Strategy

20.4.7 Recent Developments

20.4.8 SWOT Analysis

21. Other Reports in this Series

List of Exhibits:
Exhibit 1: Market Research Methodology
Exhibit 2: Global Atherectomy and Thrombectomy Devices Market 2014-2019 ($ Millions)
Exhibit 3: Global Atherectomy and Thrombectomy Devices Market Segmentation by Product Type
Exhibit 4: Global Atherectomy and Thrombectomy Devices Market 2014
Exhibit 5: Global Atherectomy Devices Market 2014-2019 ($ Millions)
Exhibit 6: Global Atherectomy Devices Market Segmentation by Procedure Type
Exhibit 7: Global Thrombectomy Devices Market 2014-2019 ($ Millions)
Exhibit 8: Global Thrombectomy Devices Market Segmentation by Product Type
Exhibit 9: Segmentation of Global Thrombectomy Devices Market by Procedures Type
Exhibit 10: Global Atherectomy and Thrombectomy Devices Market 2014-2019
Exhibit 11: Global Atherectomy and Thrombectomy Devices Market 2014-2019($ Millions)
Exhibit 12: Reimbursement for Atherectomy (Medicare)
Exhibit 13: Reimbursement for Thrombectomy (Medicare)
Exhibit 14: Geographical Segmentation of Global Atherectomy and Thrombectomy Devices Market 2014
Exhibit 15: Atherectomy and Thrombectomy Devices Market in the Americas 2014-2019 ($ Millions)
Exhibit 16: Atherectomy and Thrombectomy Devices Market in EMEA 2014-2019 ($ Millions)
Exhibit 17: Atherectomy and Thrombectomy Devices Market in APAC 2014-2019 ($ Millions)
Exhibit 18: Geographical Segmentation of Global Atherectomy and Thrombectomy Devices Market 2014-2019
Exhibit 19: Geographical Segmentation of Global Atherectomy and Thrombectomy Devices Market 2014-2019 ($ Millions)
Exhibit 20: Key Takeaways: Boston Scientific Group
Exhibit 21: Key Takeaways: Cardiovascular Systems
Exhibit 22: Key Takeaways: Medtronic
Exhibit 23: Key Takeaways: Spectranetics
Exhibit 24: Boston Scientific: Business Segmentation 2013
Exhibit 25: Boston Scientific: Business Segmentation by Revenue 2013
Exhibit 26: Boston Scientific: Business Segmentation by Revenue 2012 and 2013 ($ Billions)
Exhibit 27: Boston Scientific: Geographical Segmentation by Revenue 2012 and 2013
Exhibit 28: Cardiovascular Systems: Product Segmentation Based on Therapy Areas
Exhibit 29: Medtronic Inc.: Business Segmentation
Exhibit 30: Medtronic Inc.: Revenue by Business Segmentation 2013
Exhibit 31: Medtronic Inc.: Revenue Comparison by Business Segmentation 2012 and 2013 ($ Millions)
Exhibit 32: Medtronic Inc.: Revenue by Geographical Segmentation 2013
Exhibit 33: Spectranetics: Business Segmentation 2014
Exhibit 34: Spectranetics: Business Segmentation by Revenue 2013 and 2014 ($ Millions)
Exhibit 35: Spectranetics: Geographical Segmentation by Revenue 2014
Enquiry Before Buy